Provided by Tiger Trade Technology Pte. Ltd.

BioNTech SE

116.57
+5.685.12%
Post-market: 117.000.4300+0.37%19:59 EDT
Volume:2.96M
Turnover:345.25M
Market Cap:29.28B
PE:-15.00
High:120.33
Open:110.92
Low:110.89
Close:110.89
52wk High:124.00
52wk Low:79.52
Shares:251.20M
Float Shares:108.00M
Volume Ratio:1.03
T/O Rate:2.74%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.7726
EPS(LYR):-5.5184
ROE:-9.30%
ROA:-5.41%
PB:1.41
PE(LYR):-21.12

Loading ...

Market Chatter: BioNTech Says Germany's Health Reforms Could Impact Investment Plans

MT Newswires Live
·
Jun 04

Bernstein Sticks to Their Hold Rating for BioNTech SE (BNTX)

TIPRANKS
·
Jun 02

European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading

MT Newswires Live
·
Jun 01

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 01

Invivyd Announces Completion of Enrollment in Upsized DECLARATION Clinical Trial, a Phase 3 Pivotal Study of VYD2311, an Investigational Antibody to Prevent COVID

GlobeNewswire
·
Jun 01

Analysts Have Conflicting Sentiments on These Healthcare Companies: Pfizer (PFE) and BioNTech SE (BNTX)

TIPRANKS
·
Jun 01

Shionogi Wins FDA Nod for First Oral COVID-19 Post-Exposure Preventive Drug

TIPRANKS
·
Jun 01

BioNTech, Bristol announce interim Phase 2 data from Rosetta Lung-2a trial

TIPRANKS
·
Jun 01

Lamb Weston, FedEx, BioNTech, Zscaler, Larimar Trending With Analysts

TIPRANKS
·
May 30

Pfizer - With Authorization, Pfizer-BioNTech Covid-19 Vaccine Will Be Administered as a 10-ΜG Dose for All Children Aged 6 Months Through 11 Years

THOMSON REUTERS
·
May 29

BioNTech Board Expansion Signals Focus On Oncology Execution And Valuation Gap

Simply Wall St.
·
May 29

Astellas Pharma Cuts Director Slate After Outside Director Resigns

TIPRANKS
·
May 29

European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday

MT Newswires Live
·
May 28

Pfizer, BioNTech Prepared to Supply 2026-2027 Covid Vaccine Formula per FDA Recommendation and Upon Approval: Briefing Docs

THOMSON REUTERS
·
May 28

BioNTech Raised to Buy From Neutral by UBS

Dow Jones
·
May 28

BioNTech's Cancer Pipeline Seen Strengthening Ahead of Key Trial Results, UBS Says

MT Newswires Live
·
May 28

This Biotech Stock Is Stuck in the Red. Its Cancer Portfolio Is About to Change the Narrative. -- Barrons.com

Dow Jones
·
May 27

UBS Upgrades BioNTech to Buy From Neutral, Adjusts Price Target to $135 From $117

MT Newswires Live
·
May 27

BioNTech upgraded to Buy from Neutral at UBS

TIPRANKS
·
May 27

GeoVax Labs discontinues development of COVID-19 vaccine candidate

TIPRANKS
·
May 27